296 related articles for article (PubMed ID: 32239597)
1. Complex context relationships between DNA methylation and accessibility, histone marks, and hTERT gene expression in acute promyelocytic leukemia cells: perspectives for all-trans retinoic acid in cancer therapy.
Garsuault D; Bouyer C; Nguyen E; Kandhari R; Prochazkova-Carlotti M; Chevret E; Forgez P; Ségal-Bendirdjian E
Mol Oncol; 2020 Jun; 14(6):1310-1326. PubMed ID: 32239597
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.
Azouz A; Wu YL; Hillion J; Tarkanyi I; Karniguian A; Aradi J; Lanotte M; Chen GQ; Chehna M; Ségal-Bendirdjian E
Leukemia; 2010 Mar; 24(3):613-22. PubMed ID: 20072159
[TBL] [Abstract][Full Text] [Related]
3. Telomerase regulation by the long non-coding RNA H19 in human acute promyelocytic leukemia cells.
El Hajj J; Nguyen E; Liu Q; Bouyer C; Adriaenssens E; Hilal G; Ségal-Bendirdjian E
Mol Cancer; 2018 Apr; 17(1):85. PubMed ID: 29703210
[TBL] [Abstract][Full Text] [Related]
4. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation.
Pendino F; Flexor M; Delhommeau F; Buet D; Lanotte M; Segal-Bendirdjian E
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6662-7. PubMed ID: 11371621
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells.
Love WK; Berletch JB; Andrews LG; Tollefsbol TO
Int J Oncol; 2008 Mar; 32(3):625-31. PubMed ID: 18292940
[TBL] [Abstract][Full Text] [Related]
6. Telomerase targeting by retinoids in cells from patients with myeloid leukemias of various subtypes, not only APL.
Pendino F; Hillion J; Dudognon C; Delaunay J; Mourah S; Podgorniak MP; Lafon I; Chomienne C; Lanotte M; Dombret H; Rousselot P; Ségal-Bendirdjian E
Leukemia; 2006 Apr; 20(4):599-603. PubMed ID: 16482212
[TBL] [Abstract][Full Text] [Related]
7. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.
Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG
Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.
Schoofs T; Rohde C; Hebestreit K; Klein HU; Göllner S; Schulze I; Lerdrup M; Dietrich N; Agrawal-Singh S; Witten A; Stoll M; Lengfelder E; Hofmann WK; Schlenke P; Büchner T; Hansen K; Berdel WE; Rosenbauer F; Dugas M; Müller-Tidow C
Blood; 2013 Jan; 121(1):178-87. PubMed ID: 23152544
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines.
Abbas A; Hall JA; Patterson WL; Ho E; Hsu A; Al-Mulla F; Georgel PT
Biochem Cell Biol; 2016 Feb; 94(1):71-81. PubMed ID: 26458818
[TBL] [Abstract][Full Text] [Related]
10. CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia.
Bechter OE; Eisterer W; Dlaska M; Kühr T; Thaler J
Exp Hematol; 2002 Jan; 30(1):26-33. PubMed ID: 11823034
[TBL] [Abstract][Full Text] [Related]
11. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization.
Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E
Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843
[TBL] [Abstract][Full Text] [Related]
12. DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.
Vahidi S; Norollahi SE; Agah S; Samadani AA
J Gastrointest Cancer; 2020 Sep; 51(3):788-799. PubMed ID: 32617831
[TBL] [Abstract][Full Text] [Related]
13. [Epigenetic regulation of expression of retinoic acid receptor beta gene in leukemia cell].
Meng YS; Ma XX; Meng XQ; Wei R; Liu W; Ai GW; Zhang YX
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(48):3406-10. PubMed ID: 18476539
[TBL] [Abstract][Full Text] [Related]
14. Histone modifications patterns in tissues and tumours from acute promyelocytic leukemia xenograft model in response to combined epigenetic therapy.
Valiulienė G; Treigytė G; Savickienė J; Matuzevičius D; Alksnė M; Jarašienė-Burinskaja R; Bukelskienė V; Navakauskas D; Navakauskienė R
Biomed Pharmacother; 2016 Apr; 79():62-70. PubMed ID: 27044813
[TBL] [Abstract][Full Text] [Related]
15. Analysis of telomerase activity and RNA expression in a patient with acute promyelocytic leukemia treated with all-trans retinoic acid.
Akiyama M; Yamada O; Yanagisawa T; Fujisawa K; Eto Y; Yamada H
Pediatr Blood Cancer; 2006 Apr; 46(4):506-11. PubMed ID: 15770638
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation.
Pendino F; Sahraoui T; Lanotte M; Ségal-Bendirdjian E
Leukemia; 2002 May; 16(5):826-32. PubMed ID: 11986943
[TBL] [Abstract][Full Text] [Related]
17.
Nguyen E; Richerolle A; Sánchez-Bellver J; Varennes J; Ségal-Bendirdjian E
Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327497
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.
Berletch JB; Liu C; Love WK; Andrews LG; Katiyar SK; Tollefsbol TO
J Cell Biochem; 2008 Feb; 103(2):509-19. PubMed ID: 17570133
[TBL] [Abstract][Full Text] [Related]
19. Allele-Specific DNA Methylation and Its Interplay with Repressive Histone Marks at Promoter-Mutant TERT Genes.
Stern JL; Paucek RD; Huang FW; Ghandi M; Nwumeh R; Costello JC; Cech TR
Cell Rep; 2017 Dec; 21(13):3700-3707. PubMed ID: 29281820
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays.
Nouzova M; Holtan N; Oshiro MM; Isett RB; Munoz-Rodriguez JL; List AF; Narro ML; Miller SJ; Merchant NC; Futscher BW
J Pharmacol Exp Ther; 2004 Dec; 311(3):968-81. PubMed ID: 15302897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
